Royalty Pharma
RPRX
#804
Rank
NZ$51.36 B
Marketcap
NZ$89.21
Share price
-0.89%
Change (1 day)
54.28%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: NZ$51.36 Billion

As of May 2026 Royalty Pharma has a market cap of NZ$51.36 Billion. This makes Royalty Pharma the world's 804th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$51.36 B30.07%
2025NZ$39.49 B48.01%
2024NZ$26.68 B0.19%
2023NZ$26.63 B-3%
2022NZ$27.45 B9.57%
2021NZ$25.05 B-6.93%
2020NZ$26.92 B

End of Day market cap according to different sources

On May 17th, 2026 the market cap of Royalty Pharma was reported to be:

NZ$51.82 Billion
by Nasdaq info icon info icon
NZ$51.82 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
NZ$258.46 B 403.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.501 T 2,822.16%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$3.05 B-94.05%๐Ÿ‡บ๐Ÿ‡ธ USA